To test this hypothesis, we first analyzed immunohistochemical data from the Protein Atlas database (www.proteinatlas.org), and we found that both NOTCH1 and NOTCH3, the two NOTCH receptors that are predominantly expressed in CRC, were heterogeneously present in patient samples (Fig S5A). The gene discussed is NOTCH3; the disease is colorectal carcinoma.